MH2 Mental Health Document Analysis

Running Head: MH 0
MENTAL HEALTH
[Document subtitle]
MARCH 24, 2020
[COMPANY NAME]
[Company address]

MH 1
Table of Contents
Introduction............................................................................................................... 2
Controversy............................................................................................................ 2
Challenges............................................................................................................. 4
Conclusion................................................................................................................ 4
References................................................................................................................ 4

MH 2
Introduction
Sedatives are a kind of prescription medicine that slows down a person’s brain
activity. They are classically used to make the person feel more comfortable or relaxed.
Clinicians usually prescribe sedatives to address conditions like worry and sleep disorders.
They similarly use them as common anesthetics (Sheehan et al., 2017). Sedatives are also
called controlled substances. This indicates their manufacturing and sales are controlled.
Sedatives work through adapting certain nerve communications in the central nervous system
(CNS) to the user's brain (Wassink et al., 2015). Precisely, sedatives make the brain's
neurotransmitter named gamma-aminobutyric acid (GABA Trusted Source) function
overtime. GABA is accountable for slowing down the brain. Through increasing its level of
activity in the CNS, sedatives permit GABA to create a much robust effect on brain activity.
It is significant to be cautious when using these medicines to avoid dependence and
addiction. The use of sedatives is not recommended by different investigators. In different
parts of the world use of sedatives is controversial as it can cause multiple health issues
(Rankin, 2015). this particular assignment will discuss the controversy of the application od
psychotropic drugs to control behaviors and the challenging aspects for experienced nurses
while administrating them to the patient will be discussed.
Controversy
A psychotropic defines any medication that affects an individual's behavior, mood,
judgments, or awareness. It is a combined term for different medicines, counting prescription
drugs and usually misused medicines. Psychotropics are an extensive category of medications
that treat several different health conditions (Westbury et al., 2019). Whereas psychotropic
medications can help control a person's emotions and his or her mood, they can similarly
sometimes unfavorably impact their emotions. For instance, a user might have a difficult time
crying when he or she truly feels unhappy. They function through adjusting stages of brain

MH 3
substances, or neurotransmitters, like dopamine, gamma-aminobutyric acid (GABA),
different norepinephrine’s, and serotonin (Partridge, Lucke & Hall, 2014). Psychotropic
medicines for example antipsychotics, different anti-depressants, mood stabilizers counting
anti-epileptic drugs and lithium, the anti-anxiety medicines including benzodiazepines, many
psycho-stimulants, the beta-adrenergic blockers, and the opioid antagonists are used
extensively among individuals with intellectual disabilities and other mental health issues in
countries like Australia (del Carmen Panini et al., 2017). The degree of usage of these
medicines varies between 32 per cent and 85 per cent; some of these investigations have
stated the degree of antipsychotic application alone. These medicines are used in adding to
the current high use of medicine for physical difficulties. These medicines are used for both
psychological illness and also problematic (challenging) behavior without a license
(Karanges, Stephenson & McGregor, 2014).
Psychotropic medications transformed the management of mental disorders and
associated behavioral and symptoms. They allowed numerous individuals to be treated
deprived of chronic hospitalization. Though, medications have different side effects and
similarly introduce the problem of likely addiction. Long-standing use can be challenging.
Almost 50 percent of Australian grownups – closely 7.3 million individuals aged 16 to 85 –
will have a mental disease at some stage in their lifetime (Ćurković et al., 2016). Furthermore,
almost 600,000 young individuals aged between 4 and seventeen are exaggerated by a
clinically important mental health issue every year (Ford et al., 2017). The mental disease
significantly disturbs how an individual think, behaves and cooperates with other individuals.
Specifically, in 1949, in the Australian counselor John Cade exposed the anti-manic
characteristics of lithium and presented it for psychiatric management of people with bipolar
disorder. It was not accepted as a medicine until the late 1970s. Chlorpromazine usage for
schizophrenia issues followed in the year of 1953. Such a studied decrease in symptoms had